The Food and Drug Administration may soon change its tune on hemp-derived CBD thanks to a bill recently filed by chairman of the House Agriculture Committee.
The hope was that this testimony could demonstrate a pathway by three federal agencies represented to free up marijuana for possible federal legalization and medical research